NASDAQ:OPCH - Nasdaq - US68404L2016 - Common Stock - Currency: USD
32.74
-0.07 (-0.21%)
The current stock price of OPCH is 32.74 USD. In the past month the price decreased by -0.4%. In the past year, price increased by 8.7%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 12.09 | 90.50B | ||
CVS | CVS HEALTH CORP | 10.41 | 83.61B | ||
LH | LABCORP HOLDINGS INC | 16.56 | 20.42B | ||
DGX | QUEST DIAGNOSTICS INC | 19.16 | 19.66B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 17.13 | 16.08B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 123.08 | 13.36B | ||
HIMS | HIMS & HERS HEALTH INC | 71.7 | 11.06B | ||
DVA | DAVITA INC | 15.01 | 10.96B | ||
CHE | CHEMED CORP | 24.46 | 8.43B | ||
CRVL | CORVEL CORP | 26.63 | 5.72B | ||
GH | GUARDANT HEALTH INC | N/A | 5.19B | ||
RDNT | RADNET INC | 84.6 | 4.00B |
Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The company is headquartered in Bannockburn, Illinois and currently employs 6,015 full-time employees. The Company’s infusion services include the clinical management of infusion therapy, nursing support and care coordination. The company provides a therapy portfolio through its network of 92 full-service pharmacies and 93 stand-alone ambulatory infusion suites. The company administers a wide variety of therapies and services, including anti-infectives infusion, nutrition support, immunoglobulin infusion, chronic inflammatory disorders, neurological disorders, bleeding disorders infusion, Naven health, women’s health, heart failure, and others. Its home infusion services include medication and supplies for administration and use at home or within one of its ambulatory infusion suites, consultation and education regarding the patient’s condition and the prescribed medication nursing support, clinical monitoring and assistance in monitoring potential side effects, and assistance in obtaining reimbursement.
OPTION CARE HEALTH INC
3000 Lakeside Dr, Suite 300N
Bannockburn ILLINOIS 60015 US
CEO: John C. Rademacher
Employees: 7052
Phone: 13129402443
The current stock price of OPCH is 32.74 USD. The price decreased by -0.21% in the last trading session.
The exchange symbol of OPTION CARE HEALTH INC is OPCH and it is listed on the Nasdaq exchange.
OPCH stock is listed on the Nasdaq exchange.
16 analysts have analysed OPCH and the average price target is 39.02 USD. This implies a price increase of 19.17% is expected in the next year compared to the current price of 32.74. Check the OPTION CARE HEALTH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
OPTION CARE HEALTH INC (OPCH) has a market capitalization of 5.36B USD. This makes OPCH a Mid Cap stock.
OPTION CARE HEALTH INC (OPCH) currently has 7052 employees.
OPTION CARE HEALTH INC (OPCH) has a support level at 32.38 and a resistance level at 33.34. Check the full technical report for a detailed analysis of OPCH support and resistance levels.
The Revenue of OPTION CARE HEALTH INC (OPCH) is expected to grow by 9.88% in the next year. Check the estimates tab for more information on the OPCH EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
OPCH does not pay a dividend.
OPTION CARE HEALTH INC (OPCH) will report earnings on 2025-07-29, after the market close.
The PE ratio for OPTION CARE HEALTH INC (OPCH) is 24.07. This is based on the reported non-GAAP earnings per share of 1.36 and the current share price of 32.74 USD. Check the full fundamental report for a full analysis of the valuation metrics for OPCH.
The outstanding short interest for OPTION CARE HEALTH INC (OPCH) is 3.33% of its float. Check the ownership tab for more information on the OPCH short interest.
ChartMill assigns a technical rating of 6 / 10 to OPCH. When comparing the yearly performance of all stocks, OPCH is one of the better performing stocks in the market, outperforming 81.76% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to OPCH. OPCH scores excellent on profitability, but there are some minor concerns on its financial health.
Over the last trailing twelve months OPCH reported a non-GAAP Earnings per Share(EPS) of 1.36. The EPS decreased by -10.53% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 4.24% | ||
ROA | 6.19% | ||
ROE | 15.08% | ||
Debt/Equity | 0.79 |
ChartMill assigns a Buy % Consensus number of 85% to OPCH. The Buy consensus is the average rating of analysts ratings from 16 analysts.
For the next year, analysts expect an EPS growth of 22.07% and a revenue growth 9.88% for OPCH